TIDMGSK

RNS Number : 1322X

GlaxoSmithKline PLC

17 December 2019

GlaxoSmithKline plc

Blocklisting Application

Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 370,000 Ordinary Shares of 25p each ('Shares') to be admitted to the Official List.

The Shares are being reserved under an existing blocklisting and will be issued under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan.

When issued, the Shares will rank pari passu with the existing Ordinary Shares of 25p each.

Admission is expected to be effective on 18 December 2019.

Victoria Whyte

Company Secretary

17 December 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ALSLIFSTFLLDLIA

(END) Dow Jones Newswires

December 17, 2019 04:00 ET (09:00 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Gsk
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Gsk